The highly anticipated Forum on Surgical and Oncological Therapies was grandly held in Macau on May 24, 2025. This forum brought together top industry experts and oncology scholars to explore cutting-edge advancements in surgical techniques and cancer treatment. A key focus was placed on the potential applications of nutraceuticals in anti-cancer strategies, providing innovative insights and practical directions for cancer prevention and treatment.

At the forum, experts and scholars conducted in-depth discussions on the correlation between shark lipids and anti-cancer effects, highlighting that the bioactive compounds abundant in shark lipids may potentially modulate immune function and inhibit tumor angiogenesis.

As the pioneer in applying shark lipids to nutraceuticals, OP VITALITY was honored to participate in this forum. Our product, leveraging high-purity shark lipid extraction technology and clinically validated data, became one of the focal points in expert discussions.

SHARK LIPID Capsules

Key Ingredients: Shark lipids (containing omega-3 (Ω-3) fatty acids EPA and DHA), combined with olive oil to enhance anti-angiogenic effects.

Forum Highlights:

The forum presented compelling evidence that shark lipids demonstrate significant efficacy in inhibiting abnormal angiogenesis, suggesting their potential as an adjuvant anti-cancer therapy. Our multi-year research reveals that combining olive oil with shark lipids synergistically enhances this anti-angiogenic effect.

Additional Benefits:

Beyond angiogenesis inhibition, the EPA and DHA in shark lipids activate vascular circulation and reduce blood viscosity and thickness.